********$41.3M ARPA-H Sonogenetics Therapies********
Key Questions
What is the $41.3M ARPA-H sonogenetics project led by Salk?
Salk Institute leads a $41.3M ARPA-H effort to advance sonogenetics therapies using ultrasound-activated proteins for neuropathies. It involves a 15-year sprint to clinical trials with Nobel collaborators and multi-institution noninvasive neuro pushes.
How does sonogenetics aim to treat neuropathies?
Sonogenetics uses ultrasound to activate proteins noninvasively in the nervous system, targeting neuropathies. It builds on advances like seBEs in cancer genomics for faster therapy development.
What collaborations are involved in the sonogenetics initiative?
The project features multi-institution efforts and Nobel Prize collaborations, echoing cellular learning models from recent Nature publications.
Salk ultrasound proteins neuropathies, 15yr clinic sprint Nobel collab. Multi-institution noninvasive neuro push; echoes seBEs cancer genomics advances.
Sources (2)
Updated Apr 16, 2026